Clomipramine
Material: | 1 ml serum |
Methods: | Hochleistungsflüssigkeitschromatographie (HPLC) → Hochleistungsflüssigkeitschromatographie (HPLC) |
Indication | Therapeutic drug monitoring |
Therapeutic range | Clomipramine: Toxic: > 400 µg/l
Clomipramine + Desmethylclomipramine in total: 230 – 450 µg/l Toxic: > 450 µg/l |
Please note | Tricyclic antidepressant with minor sedative, antinociceptive and slightly activating effect. There are typical side effects of this type of pharmaceuticals (dry mouth, hypotension, constipation, clinical deterioration of existing glaucoma, arrhythmia in case of overdosing etc.). |
Accredited | ja |
More Results for the letter C
- C-peptide in the serum (CPEP)
- C1-esterase inhibitor (C1-INH) (C1EA, C1EH)
- Activity evaluation, protein evaluation
- C2-complement (C2S)
- C3-complement in the serum (C3)
- C3-nephritis factor (C3NF)
- C3NeF
- C4-complement in the serum (C4)
- CA 125 (CA 125)
- CA 15-3 (CA15)
- CA 19-9 (CA19)
- CA 72-4 (CA72)
- Cadmium (CAD)
- Cd
- Caeruloplasmin (α2-) (CAER(a2))
- Caffeine (COFF)
- Calcitonin (CALC)
- hCT, human calcitonin
- Calcium in serum (CA)
- Ca
- Calcium in urine (CAU)
- Calcium, ionized, in serum (CAI)
- Calprotectin (ECALP)
- Calymmatobacterium granulomatis (CALY)
- Donovaniosis
- Campylobacter jejuni/coli infection (KCAMP, ECAMP, CAMPG, CAMPA)
- Canary serum, feather, excrement antibodies (IgG) (CANA)
- Candida infection (KCAND)
- Cannabinoids (CANN)
- Tetrahydrocannabinol, delta-9 THC, cannabis, weed, marihuana, hash
- Carbamazepine (CARB)
- Carboxyhemoglobin (COHB)
- CO-Hb
- Cardiac muscle antibodies (HMA)
- Carnitine ratio: Acyl carnitine / free carnitine (CARNF)
- Carotene (β-) (CARO(b))
- Group of carotenoids with provitamine A activity
- Cartilage autoantibodies (KNOR)
- Catecholamines in plasma (KATP)